Walgreens Boots Alliance (NASDAQ:WBA) Issues FY24 Earnings Guidance (2024)

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share guidance of $2.80-$2.95 for the period, compared to the consensus earnings per share estimate of $3.20. Walgreens Boots Alliance also updated its FY 2024 guidance to 2.800-2.950 EPS.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA traded down $3.47 during mid-day trading on Thursday, reaching $12.19. The stock had a trading volume of 132,635,796 shares, compared to its average volume of 14,071,562. The firm has a 50 day moving average price of $16.72 and a two-hundred day moving average price of $20.33. The stock has a market capitalization of $10.52 billion, a P/E ratio of -1.74, a P/E/G ratio of 0.98 and a beta of 0.78. Walgreens Boots Alliance has a one year low of $11.68 and a one year high of $31.32. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance's quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.16 EPS. As a group, analysts expect that Walgreens Boots Alliance will post 3.21 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were paid a $0.25 dividend. The ex-dividend date was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 8.20%. Walgreens Boots Alliance's dividend payout ratio (DPR) is currently -14.29%.

Analyst Ratings Changes

A number of equities analysts have commented on WBA shares. TD Cowen decreased their price target on Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating on the stock in a research note on Wednesday, April 3rd. Bank of America reduced their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an underperform rating on the stock in a research note on Tuesday, March 26th. Raymond James reissued a market perform rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft reduced their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating on the stock in a research note on Wednesday, April 3rd. Finally, Evercore ISI reduced their target price on Walgreens Boots Alliance from $18.00 to $17.00 and set an in-line rating on the stock in a research note on Monday, June 3rd. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of Hold and a consensus price target of $23.07.

Get Our Latest Research Report on WBA

Insider Activity

In other news, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now owns 3,000 shares of the company's stock, valued at $54,150. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company's stock.

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

• Five stocks we like better than Walgreens Boots Alliance
• Comparing and Trading High PE Ratio Stocks
• BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
• What Are the U.K. Market Holidays? How to Invest and Trade
• Progress Software Stock Back in the Green After Beating Forecasts
• Short Selling: How to Short a Stock
• Goldman Sachs Raises Stock Target for Affirm: Key Insights

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here